Brief: Bergenbio H1 Operating Loss NOK 54.6 Mln
20/08/2025 07:10
Aug 20 (Reuters) - Bergenbio ASA BGBIO.OL: H1 OPERATING LOSS FOR FIRST HALF WAS NOK 54.6 MILLION H1 NET CASH FLOW FOR FIRST HALF WAS NEGATIVE BY NOK 73.9 MILLION Source text: ID:nWkr3ZM9l5 Further company coverage: BGBIO.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee